Buckingham Strategic Wealth’s Tetraphase Pharmaceuticals, Inc. TTPH Stock Holding History

Buckingham Strategic Wealth’s Portfolio TTPH Stock Details TTPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-595	Closed	-$46K	–	245
2016 Q3	$46K	Hold	595	–	–	0.02%	226
2016 Q2	$51K	Hold	595	–	–	0.02%	243
2016 Q1	$55K	Hold	595	–	–	0.02%	233
2015 Q4	$119K	Buy	+595	New	+$119K	0.04%	201

Other funds holding TTPH

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

Buckingham Strategic Wealth's TTPH Position: Q4 2016 in Review

Buckingham Strategic Wealth sold out of Tetraphase Pharmaceuticals, Inc. (TTPH) in Q4 2016, closing a stake of 595 shares — an estimated $46K sold.

Buckingham Strategic Wealth first reported a position in TTPH in Q4 2015 and held it in 4 quarters. The position peaked at $119K in Q4 2015. 91 funds tracked by Wall St. Rank hold TTPH as of Q4 2016.

Buckingham Strategic Wealth reported no remaining Tetraphase Pharmaceuticals, Inc. position as of Q4 2016 after selling out during the quarter.
Buckingham Strategic Wealth sold 595 Tetraphase Pharmaceuticals, Inc. shares in Q4 2016, an estimated $46K.
Buckingham Strategic Wealth first reported a position in Tetraphase Pharmaceuticals, Inc. in Q4 2015 and held it in 4 quarters.
Buckingham Strategic Wealth's Tetraphase Pharmaceuticals, Inc. position peaked at $119K in Q4 2015.
91 funds tracked by Wall St. Rank held Tetraphase Pharmaceuticals, Inc. as of Q4 2016.

Based on Buckingham Strategic Wealth's 13F filing for Q4 2016, filed 30 Jan 2017.